Loading stock data…
$0.14+0.00 (+1.34%)
Endovia Health Sciences, Inc.
Endovia Health Sciences, Inc. in the Healthcare sector is trading at $0.14 with a market capitalization of $2M. The stock is currently near its 52-week low of $0.14, remaining 88.1% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 14 is oversold, raising the odds of a near-term bounce. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↓ | $4,224↑ | -$365,206 | $0 | $0 |
| Gross Profit | $0↓ | $1,848↓ | $47,341 | $0 | $0 |
| Operating Income | -$2.01M↓ | -$978,970↓ | -$976,411↑ | -$9.54M↓ | -$1.50M |
| Net Income | -$2.05M↑ | -$2.14M↑ | -$3.21M↑ | -$9.89M↓ | -$8.49M |
Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Lati...